No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer

No abstract is available for this paper.

• Publication year

  1999

• Venue

  The Prostate

• Publication date

  1999-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0045(19990601)39:4<280::AID-PROS8>3.0.CO;2-FPMID 10344217
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.

  1998cited by this paper
• Cancer statistics, 1998

  1998cited by this paper
• Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43.

  1998cited by this paper
• Evidence for a prostate cancer susceptibility locus on the X chromosome.

  1998cited by this paper
• Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia.

  1997cited by this paper
• A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.

  1997cited by this paper
• Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.

  1997cited by this paper
• Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

  1997cited by this paper
• BRCA2 mutation in Icelandic prostate cancer patients

  1997cited by this paper
• The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

  1997cited by this paper
• Environmental and genetic factors: a possible link with prostate cancer

  1997cited by this paper
• Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

  1996cited by this paper
• Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds.

  1996cited by this paper
• Germ-line BRCA1 mutations in selected men with prostate cancer.

  1996cited by this paper
• Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search

  1996cited by this paper
• Breast and prostate cancer in the relatives of men with prostate cancer.

  1996cited by this paper
• The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

  1996cited by this paper
• Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families

  1996cited by this paper
• A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.

  1996cited by this paper
• Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

  1996cited by this paper
• Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.

  1995cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1995cited by this paper
• The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

  1995cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

  1994cited by this paper
• Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

  1994cited by this paper
• Mendelian inheritance of familial prostate cancer.

  1992cited by this paper
• Protocols for an improved detection of point mutations by SSCP.

  1991cited by this paper
• Linkage of early-onset familial breast cancer to chromosome 17q21.

  1990cited by this paper
• Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

  1989cited by this paper
• Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

  1989cited by this paper
• Concerning a familial association between breast cancer and both prostatic and uterine malignancies

  1974cited by this paper
• Correlations of international cancer death rates. An epidemiological exercise

  1967cited by this paper

• Genetic determinants of prostate cancer predisposition in Ashkenazi Jews.

  2025cites this paper
• Precision Care for Hereditary Urologic Cancers: Genetic Testing, Counseling, Surveillance, and Therapeutic Implications

  2025cites this paper
• Mutational spectrum of DNA damage and mismatch repair genes in prostate cancer

  2023cites this paper
• Prevalence of Germline BRCA1/2 Variants in Ashkenazi and Non-Ashkenazi Prostate Cancer Populations: A Systematic Review and Meta-Analysis

  2023cites this paper
• Prostate Cancer Predisposition.

  2021cites this paper
• Next-generation sequencing of BRCA1 and BRCA2 genes in Moroccan prostate cancer patients with positive family history

  2021cites this paper
• Clinicopathological and molecular characteristics of prostate cancer diagnosed in young men aged up to 45 years

  2020cites this paper
• Le carcinome intracanalaire de la prostate : indication potentielle pour la radiothérapie adjuvante

  2019cites this paper
• The Prostate

  2019cites this paper
• Genetic predisposition to prostate cancer: Update and future perspectives.

  2015cites this paper
• Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study

  2015cites this paper
• The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer

  2015cites this paper
• Clinical features and management of BRCA1 and BRCA2-associated prostate cancer.

  2014influential citation
• The role of BRCA1 and BRCA2 in prostate cancer.

  2013cites this paper
• Hereditary Prostate Cancer and Genetic Risk

  2012cites this paper
• The role of BRCA1 and BRCA2 in prostate cancer.

  2012cites this paper
• BRCA1 mutations do not increase prostate cancer risk: Results from a meta‐analysis including new data

  2011cites this paper
• Biological and clinical significance of BRCA2

  2011cites this paper
• Inherited Susceptibility of Aggressive Prostate Cancer

  2010cites this paper
• Prostate Cancer in Special Populations

  2010cites this paper
• Associations of High-Grade Prostate Cancer with BRCA1 and BRCA2 Founder Mutations

  2009cites this paper
• No evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees

  2009cites this paper
• Analysis of the gene coding for the BRCA2‐Interacting protein PALB2 in hereditary prostate cancer

  2008cites this paper
• The Role of the BRCA2 Gene in Susceptibility to Prostate Cancer Revisited

  2008cites this paper
• Prostate Cancer Epidemiological studies of Risk Factors

  2008cites this paper
• Common Variation in the BRCA1 Gene and Prostate Cancer Risk

  2007cites this paper
• Common Variation in the BRCA 1 Gene and Prostate Cancer Risk

  2007cites this paper
• Linkage Studies of Prostate Cancer Families to Identify Susceptibility Genes

  2007cites this paper
• Germline Mutations in the BRCA2 Gene and Susceptibility to Hereditary Prostate Cancer

  2007cites this paper
• BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families

  2007cites this paper
• Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer

  2007cites this paper
• Androgen receptor in prostate cancer.

  2004cites this paper
• Truncating BRCA1 Mutations Are Uncommon in a Cohort of Hereditary Prostate Cancer Families with Evidence of Linkage to 17q Markers

  2004cites this paper
• Familial association of histology specific breast cancers with cancers at other sites

  2004cites this paper
• Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.

  2004cites this paper
• Truncating BRCA 1 Mutations Are Uncommon in a Cohort of Hereditary Prostate Cancer Families with Evidence of Linkage to 17 q Markers

  2004cites this paper
• The BRCA1 and BRCA2 genes

  2004cites this paper
• Genetic counseling for prostate cancer risk

  2003cites this paper
• BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland

  2003cites this paper
• Evaluation of familial clustering of breast and prostate cancer in the Minnesota Breast Cancer Family Study.

  2003cites this paper
• BRCA1 gene in breast cancer

  2003cites this paper
• Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.

  2003cites this paper
• International Congress on Hormonal Steroids and Hormones and Cancer Prostate cancer susceptibility genes: lessons learned and challenges posed

  2003cites this paper
• Androgens and androgen receptor in prostate and ovarian malignancies.

  2003cites this paper
• Cancer Incidence in BRCA1 mutation carriers.

  2002cites this paper
• Counseling the at risk patient in the BRCA1 and BRCA2 Era.

  2002cites this paper
• Perspective: prostate cancer susceptibility genes.

  2002cites this paper
• Hereditary breast/ovarian cancer – pitfalls in genetic counseling

  2001cites this paper
• Germ line mutations associated with breast cancer susceptibility.

  2001cites this paper
• Hereditary breast cancer.

  2001cites this paper
• BRCA2 mutation in a family with hereditary prostate cancer

  2001cites this paper
• BRCA1 and Prostate Cancer

  2001cites this paper
• Hereditary Prostate Cancer

  2001cites this paper
• New insights and candidate genes and their implications for care of patients with hereditary prostate cancer

  2000cites this paper
• BRCA1 and BRCA2 have a limited role in familial prostate cancer.

  2000cites this paper
• The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

  2000cites this paper
• The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.

  2000cites this paper
• Cancer risk in families with hereditary prostate carcinoma

  2000cites this paper
• GENETIC EPIDEMIOLOGY OF HEREDITARY PROSTATE CANCER IN FINLAND: DISCOVERY OF NOVEL SUSCEPTIBILITY LOCI

  1999cites this paper
• The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.

  1999cites this paper
• Voiding dysfunction and female urology

  1997cites this paper